Enlitic, Inc. (ASX:ENL)

Market Cap	29.16M
Revenue (ttm)	4.40M
Net Income (ttm)	-23.27M
Shares Out	833.17M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	161,106
Average Volume	513,281
Open	0.0370
Previous Close	0.0350
Day's Range	0.0340 - 0.0370
52-Week Range	0.0210 - 0.1050
Beta	n/a
RSI	44.97
Earnings Date	Aug 29, 2025

About Enlitic

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, and ultrasound images, as well as licenses its products to healthcare providers and original equipment manufacturers. Its healthcare data solutions include ENDEX, a platform that uses artificial intelligence to standardize medical imaging data; ENCOG, an AI enabled data anony...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2014
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ENL

Financial Performance

In 2024, Enlitic's revenue was $1.20 million, an increase of 115.54% compared to the previous year's $557,677. Losses were -$15.24 million, -2.02% less than in 2023.

Financial numbers in USD